Qinghai University Affiliated Hospital | China
Ziyang Qiang is a dedicated urologist and clinical researcher currently serving as an attending urologist at the affiliated hospital of Qinghai University, China, under the supervision of Prof. Guojun Chen. He earned his bachelor’s degree in clinical medicine and later completed a master’s degree in surgery at Ningxia Medical University under Prof. Lianghong MA, where his thesis focused on the effects of the pi3k inhibitor ly294002 on the proliferation and apoptosis of prostate cancer cell line pc-3. He further expanded his research expertise at the University hospital Halle, Germany, under Prof. P. Fornara, working on minimally invasive surgery and its comparison with open surgical procedures. Over the years, he has built a strong academic and clinical foundation, combining research insight with practical surgical experience. His scholarly contributions include several publications in peer-reviewed journals, reflecting growing recognition in the field of urology. According to available databases, Dr. Ziyang Qiang has an h-index of 8, with approximately 490 citations across about 5 documents, highlighting his active engagement in Bio-Inspired Robot Design research. his work bridges clinical innovation and academic inquiry, contributing meaningfully to advancements in urological surgery and evidence-based medical practice.
Profile: Orcid
Featured Publications
Qiang, Z., Zhang, B., Li, T., Ma, L., Kong, X., & Chen, S. (2025, October). Dysbiotic gut microbiota correlates with altered serum and urinary biomarkers in recurrent calcium oxalate stone patients. International Journal of General Medicine, 18, Article S549804.
Wang, J., Fan, M., Qiang, Z., Ren, H., Chen, H., & Dai, Y. (2025, October 9). Global research trends of robotic-assisted surgery in urogynecology and reconstructive pelvic surgery: A bibliometric and visualization analysis based on Web of Science. Journal of Robotic Surgery.
Qiang, Z. (2025, October 1). Risk factor analysis and prediction model establishment for urinary incontinence after laparoscopic radical prostatectomy. Journal of the College of Physicians and Surgeons Pakistan, 35(10), 1301–1307.
Niu, S., Xia, D., Wang, B., Wang, X., Zhang, Q., Wang, J., Jin, X., Mao, L., Ruan, Y., Wang, H., … Qiang, Z. (2025, April). Real-world effectiveness of rezvilutamide plus androgen deprivation therapy in patients with low-volume, metastatic hormone-sensitive prostate cancer: A retrospective multicenter study. Translational Andrology and Urology, 14(4), 239–249.
Zhang, J., He, J., Qiang, Z., Zhang, J., Hao, F., Song, S., Chen, X., Ma, W., & Li, Y. (2024, December 18). Methyltransferase like 13 promotes malignant behaviors of bladder cancer cells through targeting PI3K/AKT signaling pathway. Open Life Sciences, 19(12), 981–990.